nad has been researched along with 2-amino-3-methylimidazo(4,5-f)quinoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Shakra, A; Ioannides, C; Walker, R | 1 |
| Akaike, T; Maeda, H; Sawa, T; Yubisui, T | 1 |
2 other study(ies) available for nad and 2-amino-3-methylimidazo(4,5-f)quinoline
| Article | Year |
|---|---|
Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences.
Topics: Animals; Aroclors; Biotransformation; Chlorodiphenyl (54% Chlorine); Cytosol; In Vitro Techniques; Liver; Male; Methylcholanthrene; Microsomes, Liver; Mutagens; NAD; Phenobarbital; Quinolines; Rats; Rats, Inbred Strains; Species Specificity; Subcellular Fractions | 1986 |
Free radical generation from heterocyclic amines by cytochrome b5 reductase in the presence of NADH.
Topics: Cytochrome Reductases; Cytochrome-B(5) Reductase; DNA Damage; Free Radicals; Humans; NAD; Quinolines; Quinoxalines; Recombinant Proteins | 1999 |